require a better description of the radiobiological effect of hadrons in tissue that cannot be
adequately reflected, as in conventional radiation therapy, by a single dosimetric quantity,
e.g. mean absorbed dose to target volume. MedAustron, the Austrian centre for ion-beam therapy, in collaboration with the University of Rome, Tor Vergata is developing semi-conductor diamond detectors for dosimetry and microdosimetry in ion-beam therapy. The potential of such (micro)dosimeters with respect to alpha radionuclide target therapy, 90Y radio-embolization, and other treatment modalities is under investigation in the present project.
Kooperationen im Projekt
Tel.:+49 391 6718863